Mary Vore

6.9k total citations
159 papers, 5.6k citations indexed

About

Mary Vore is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Mary Vore has authored 159 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 43 papers in Pediatrics, Perinatology and Child Health and 34 papers in Molecular Biology. Recurrent topics in Mary Vore's work include Drug Transport and Resistance Mechanisms (94 papers), Pharmacological Effects and Toxicity Studies (29 papers) and Pharmacogenetics and Drug Metabolism (20 papers). Mary Vore is often cited by papers focused on Drug Transport and Resistance Mechanisms (94 papers), Pharmacological Effects and Toxicity Studies (29 papers) and Pharmacogenetics and Drug Metabolism (20 papers). Mary Vore collaborates with scholars based in United States, Argentina and Thailand. Mary Vore's co-authors include Daret K. St. Clair, Aldo D. Mottino, Tim Hoffman, D. Allan Butterfield, Rukhsana Sultana, Phillip M. Gerk, Paiboon Jungsuwadee, Liyue Huang, Jingsong Cao and D. Allan Butterfield and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Mary Vore

158 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Vore United States	42	2.8k	1.3k	1.1k	1.0k	953	159	5.6k
Toshiya Katsura Japan	49	3.7k 1.3×	2.4k 1.9×	2.0k 1.8×	626 0.6×	1.0k 1.1×	144	7.0k
Gabriele Jedlitschky Germany	50	5.1k 1.9×	2.1k 1.6×	2.4k 2.2×	683 0.7×	232 0.2×	104	7.4k
Gerhard Burckhardt Germany	41	2.8k 1.0×	2.6k 2.0×	1.3k 1.2×	517 0.5×	456 0.5×	164	6.3k
Seok Ho South Korea	34	2.7k 1.0×	2.0k 1.5×	1.2k 1.1×	515 0.5×	238 0.2×	79	6.1k
Yoshimichi Sai Japan	49	4.3k 1.6×	2.9k 2.2×	2.1k 1.9×	737 0.7×	230 0.2×	185	8.6k
Shun Higuchi Japan	38	2.1k 0.8×	867 0.7×	1.6k 1.5×	1.2k 1.2×	162 0.2×	173	5.2k
Naohiko Anzai Japan	46	2.1k 0.8×	2.9k 2.2×	838 0.8×	553 0.5×	365 0.4×	213	6.8k
Hong‐Hao Zhou China	38	1.3k 0.5×	1.3k 1.0×	554 0.5×	1.4k 1.4×	351 0.4×	165	4.7k
Akira Tsuji Japan	50	5.3k 1.9×	2.7k 2.1×	2.5k 2.2×	1.1k 1.1×	222 0.2×	182	9.5k
Jean‐Michel Scherrmann France	42	2.0k 0.7×	1.6k 1.2×	934 0.9×	435 0.4×	181 0.2×	114	5.0k

Countries citing papers authored by Mary Vore

Since Specialization

Citations

This map shows the geographic impact of Mary Vore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Vore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Vore more than expected).

Fields of papers citing papers by Mary Vore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Vore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Vore. The network helps show where Mary Vore may publish in the future.

Co-authorship network of co-authors of Mary Vore

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Vore. A scholar is included among the top collaborators of Mary Vore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Vore. Mary Vore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vore, Mary. (2023). ABCC subfamily in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023(1). 2 indexed citations

Zhang, Wei, et al.. (2016). Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts. Toxicological Sciences. 151(1). 44–56. 17 indexed citations

Carroll, Dustin, Haining Zhu, Christian M. Paumi, et al.. (2016). Simultaneous quantitation of oxidized and reduced glutathione via LC-MS/MS: An insight into the redox state of hematopoietic stem cells. Free Radical Biology and Medicine. 97. 85–94. 28 indexed citations

Deng, Jun, Wei Zhang, Manjula Sunkara, et al.. (2015). Elevated Glutathione Is Not Sufficient to Protect against Doxorubicin-Induced Nuclear Damage in Heart in Multidrug Resistance–Associated Protein 1 (Mrp1/Abcc1) Null Mice. Journal of Pharmacology and Experimental Therapeutics. 355(2). 272–279. 16 indexed citations

Ruiz, María Laura, Juan Pablo Rigalli, Silvina Stella Maris Villanueva, et al.. (2012). Induction of Hepatic Multidrug Resistance-Associated Protein 3 by Ethynylestradiol Is Independent of Cholestasis and Mediated by Estrogen Receptor. Drug Metabolism and Disposition. 41(2). 275–280. 17 indexed citations

Jungsuwadee, Paiboon, Tianyong Zhao, Christian M. Paumi, et al.. (2012). The G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenal. Pharmacogenetics and Genomics. 22(4). 273–284. 22 indexed citations

Boaglio, Andrea C., Andrés E. Zucchetti, Enrique J. Sánchez Pozzi, et al.. (2010). Phosphoinositide 3-Kinase/Protein Kinase B Signaling Pathway Is Involved in Estradiol 17β-D-Glucuronide–Induced Cholestasis: Complementarity with Classical Protein Kinase C. Hepatology. 52(4). 1465–1476. 46 indexed citations

Villanueva, Silvina Stella Maris, María Laura Ruiz, Marcelo G. Luquita, et al.. (2009). Regulation of Expression and Activity of Rat Intestinal Multidrug Resistance-Associated Protein 2 by Cholestatic Estrogens. Drug Metabolism and Disposition. 37(6). 1277–1285. 13 indexed citations

Ruiz, María Laura, Silvina Stella Maris Villanueva, Marcelo G. Luquita, et al.. (2006). ETHYNYLESTRADIOL INCREASES EXPRESSION AND ACTIVITY OF RAT LIVER MRP3. Drug Metabolism and Disposition. 34(6). 1030–1034. 24 indexed citations

10.

Gerk, Phillip M., et al.. (2006). Human Multidrug Resistance Protein 2 Transports the Therapeutic Bile Salt Tauroursodeoxycholate. Journal of Pharmacology and Experimental Therapeutics. 320(2). 893–899. 26 indexed citations

11.

Jungsuwadee, Paiboon, Marsha P. Cole, Rukhsana Sultana, et al.. (2006). Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice. Molecular Cancer Therapeutics. 5(11). 2851–2860. 38 indexed citations

12.

Golub, Mari S., Lucio G. Costa, Kevin M. Crofton, et al.. (2005). NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate. Birth Defects Research Part B Developmental and Reproductive Toxicology. 74(4). 300–381. 19 indexed citations

13.

Joshi, Gururaj, Rukhsana Sultana, Jitbanjong Tangpong, et al.. (2005). Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: Insight into chemobrain. Free Radical Research. 39(11). 1147–1154. 144 indexed citations

14.

Ruiz, María Laura, Silvina Stella Maris Villanueva, Marcelo G. Luquita, et al.. (2004). Mechanisms involved in spironolactone-induced choleresis in the rat. Biochemical Pharmacology. 69(3). 531–539. 21 indexed citations

15.

Mottino, Aldo D., Fernando A. Crocenzi, Enrique J. Sánchez Pozzi, et al.. (2004). Role of microtubules in estradiol-17β-d-glucuronide-induced alteration of canalicular Mrp2 localization and activity. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(2). G327–G336. 42 indexed citations

16.

Gerk, Phillip M., Wěi Li, & Mary Vore. (2004). ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE. Drug Metabolism and Disposition. 32(10). 1139–1145. 25 indexed citations

17.

Cao, Jingsong, Bruno Stieger, Peter J. Meier, & Mary Vore. (2002). Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. American Journal of Physiology-Gastrointestinal and Liver Physiology. 283(3). G757–G766. 65 indexed citations

18.

Cao, Jingsong, Liyue Huang, Yong Liu, et al.. (2001). Differential Regulation of Hepatic Bile Salt and Organic Anion Transporters in Pregnant and Postpartum Rats and the Role of Prolactin. Hepatology. 33(1). 140–147. 72 indexed citations

19.

Zimniak, Piotr, Irma Panfil, A Radominska, et al.. (1992). Identification of an anion-transport ATPase that catalyzes glutathione conjugate-dependent ATP hydrolysis in canalicular plasma membranes from normal rats and rats with conjugated hyperbilirubinemia (GY mutant). Archives of Biochemistry and Biophysics. 292(2). 534–538. 20 indexed citations

20.

Teo, Steve & Mary Vore. (1990). Mirex exposure inhibits the uptake of estradiol-17β(β-d-glucuronide), taurocholate, and l-alanine into isolated rat hepatocytes. Toxicology and Applied Pharmacology. 104(3). 411–420. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact